More than 1,600 patients have received a new heart through the adult heart transplant program at the Smidt Heart Institute. The program has been the largest in the U.S. since 2010, and it is the flagship of the Advanced Heart Disease Program. We have made pioneering discoveries and are internationally recognized as having unique expertise in treating highly sensitized patients, amyloid patients and patients bridged from mechanical circulatory support. As a major referral center for complex patients from across the country, we offer deeply individualized care plans resulting in superior outcomes that consistently surpass government benchmarks.
Cedars-Sinai performs the most adult heart transplants in the U.S.
A Patient's Guide to Heart Transplant
Learn what to expect from your heart transplant care at Cedars-Sinai. You'll find out about preparing for, receiving and recovering from your heart transplant, donor matches, medications, support groups and more.
Find answers to some commonly asked questions about heart transplant at Cedars-Sinai.
The Heart Transplant Program offers specialized expertise in emerging areas.
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab
Heart transplantation is the optimal therapy for patients with irreversible, end-stage heart disease. However, long-term outcomes are limited by a broad range of host inflammatory and immune responses that occur early following transplantation. This phase 2, prospective, multi-center, randomized, placebo-controlled clinical trial has been designed to:
- Determine the impact of early tocilizumab treatment on heart transplant outcomes
- Investigate the effects of tocilizumab therapy on inflammatory and alloimmune responses
- Define the utility of several noninvasive biomarkers as risk assessment, diagnostic and predictive testing strategies.
For more information on this trial, please contact the study coordinator at 310-248-7129.
Medical Professionals & Postgraduates
Cedars-Sinai offers programs for graduate studies, continuing medical education, conferences, symposiums and other professional opportunities for learning, discovery and training.
For physician-to-physician questions or referrals call our team at 310-423-5460.